Three pharmaceutical companies have left the brand-drug lobby PhRMA following the passage of Democrats’ drug pricing law in 2022. This resulted in the organization collecting $100 million less in annual membership dues, according to new tax filings. This development highlights the impact of the new legislation on industry associations and their members. For more information, the full story can be read on STAT+.
Source link
STAT+: PhRMA dues fell almost $100 million as major drugmakers exited
